Bodo Niggemann
Research Subjects
Research Interests
Bodo Niggemann has a total of 489 co-authors. Here are the top co-authors by number of shared publications:
- Torsten Zuberbier
Charité – University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Institute of Allergology Berlin Germany
8 shared publications Joachim Saloga
7 shared publicationsJörg Kleine-Tebbe
7 shared publicationsStefan Vieths
7 shared publicationsStephan Erdmann
7 shared publicationsThomas Fuchs
7 shared publications
Latest Publications
- Open Access
- 26 September 2022
- Published by Wiley in Pediatric Pulmonology
- Vol. 57 (12) , 3027-3034
“Psychological characteristics of functional respiratory disorders in children and adolescents—Pilot study”
Background: Aim of our prospective, multicenter, nonrandomized study was to identify characteristic features and similarities of patients with functional respiratory disorders regarding socio‐familial and behavioral aspects, in comparison with controls in a cross‐sectional analysis using standardized psychological questionnaires. Furthermore, we investigated the longitudinal outcome of symptoms, effects of primary interventions and the stability of psychological traits 6 months after diagnosis and primary intervention.Methods: Initially, 106 patients (68 females, 27 males) and 58 controls (33 females, 25 males) were recruited for the study. Mean age was 12.6 years in patients and 11.9 years in controls.Results: The child behavior checklist (CBCL) showed significantly increased scores for anxious/depressed (p = 0.002) and schizoid/obsessive (p = 0.001) behavior in patients. A trend was evident for internalizing behavior (p = 0.009) and for a higher total score (p = 0.008). In the self‐assessment youth self‐report (YSR), there was a trend towards higher values for anxious/depressed behavior in patients (p = 0.06) and towards more externalizing behavior (p = 0.029) in the control group. After 6 months, 31% of the patients were free of symptoms, 42% had improved. For themselves, parents reported a decreased burden from 56% to 23% (p < 0.001) and decreased impairment from 57% to 30% (p < 0.008). For their children, parents reported a decrease from 45% to 16% (p < 0.0001) and from 74% to 37% (p < 0.0001), respectively. A longitudinal comparison from T1 to T2 showed no statistically significant changes in all three psychological questionnaires (CBCL, YSR, and SOMS‐KJ).Conclusions: In summary, we show that patients with functional respiratory disorders differ from healthy subjects, with internalizing behavior being a characteristic trait. The outcome in terms of symptoms, perceived psycho‐familial burden and impairment after 6 months is encouraging. However, we are aware that our preliminary data offer thought‐provoking impulses rather than firm findings.
- 26 September 2022
- Published by Wiley in Pediatric Pulmonology
- Vol. 57 (12) , 3027-3034
Open Access“Psychological characteristics of functional respiratory disorders in children and adolescents—Pilot study”
Background: Aim of our prospective, multicenter, nonrandomized study was to identify characteristic features and similarities of patients with functional respiratory disorders regarding socio‐familial and behavioral aspects, in comparison with controls in a cross‐sectional analysis using standardized psychological questionnaires. Furthermore, we investigated the longitudinal outcome of symptoms, effects of primary interventions and the stability of psychological traits 6 months after diagnosis and primary intervention.Methods: Initially, 106 patients (68 females, 27 males) and 58 controls (33 females, 25 males) were recruited for the study. Mean age was 12.6 years in patients and 11.9 years in controls.Results: The child behavior checklist (CBCL) showed significantly increased scores for anxious/depressed (p = 0.002) and schizoid/obsessive (p = 0.001) behavior in patients. A trend was evident for internalizing behavior (p = 0.009) and for a higher total score (p = 0.008). In the self‐assessment youth self‐report (YSR), there was a trend towards higher values for anxious/depressed behavior in patients (p = 0.06) and towards more externalizing behavior (p = 0.029) in the control group. After 6 months, 31% of the patients were free of symptoms, 42% had improved. For themselves, parents reported a decreased burden from 56% to 23% (p < 0.001) and decreased impairment from 57% to 30% (p < 0.008). For their children, parents reported a decrease from 45% to 16% (p < 0.0001) and from 74% to 37% (p < 0.0001), respectively. A longitudinal comparison from T1 to T2 showed no statistically significant changes in all three psychological questionnaires (CBCL, YSR, and SOMS‐KJ).Conclusions: In summary, we show that patients with functional respiratory disorders differ from healthy subjects, with internalizing behavior being a characteristic trait. The outcome in terms of symptoms, perceived psycho‐familial burden and impairment after 6 months is encouraging. However, we are aware that our preliminary data offer thought‐provoking impulses rather than firm findings.
- 1 February 2018
- Published by Springer Nature in Der Pneumologe
- Vol. 15 (1) , 49-52
Habit cough in childhood and adolescence. Position paper of the working group on reactive airways dysfunction syndrome of the Society for Pediatric Pneumology
- 1 February 2018
- Published by Springer Nature in Der Pneumologe
- Vol. 15 (1) , 49-52
Habit cough in childhood and adolescence. Position paper of the working group on reactive airways dysfunction syndrome of the Society for Pediatric Pneumology
- 11 September 2017
- Published by Springer Nature in Pädiatrie & Pädologie
- Vol. 52 (5) , 199-203
Habitueller Husten im Kindes- und Jugendalter
- 11 September 2017
- Published by Springer Nature in Pädiatrie & Pädologie
- Vol. 52 (5) , 199-203
Habitueller Husten im Kindes- und Jugendalter
- 15 May 2017
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 165 (6) , 518
Beachtenswerte Aspekte der Adrenalinautoinjektion
- 15 May 2017
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 165 (6) , 518
Beachtenswerte Aspekte der Adrenalinautoinjektion
- 20 April 2017
- Published by Wiley in Acta Paediatrica
- Vol. 106 (7) , 1067-1069
Therapeutic options for dysfunctional breathing in children and adolescents
- 20 April 2017
- Published by Wiley in Acta Paediatrica
- Vol. 106 (7) , 1067-1069
Therapeutic options for dysfunctional breathing in children and adolescents
- Open Access
- 30 December 2016
- Published by Wiley in Clinical and Translational Allergy
- Vol. 6 (1) , 1-14
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA—disseminated and implemented in over 70 countries globally—is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care pathways for the management of rhinitis and asthma by a multi-disciplinary group and by patients themselves. An app (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.
- 30 December 2016
- Published by Wiley in Clinical and Translational Allergy
- Vol. 6 (1) , 1-14
Open AccessARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA—disseminated and implemented in over 70 countries globally—is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care pathways for the management of rhinitis and asthma by a multi-disciplinary group and by patients themselves. An app (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.
- 20 December 2016
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 28 (2) , 201-203
Severe anaphylaxis requiring intensive care during oral food challenge–It is not always peanuts
- 20 December 2016
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 28 (2) , 201-203
Severe anaphylaxis requiring intensive care during oral food challenge–It is not always peanuts
- 19 December 2016
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 165 (3) , 248-253
Praktischer Einsatz von Adrenalinautoinjektoren
- 19 December 2016
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 165 (3) , 248-253
Praktischer Einsatz von Adrenalinautoinjektoren
- 28 October 2016
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 165 (5) , 433-436
Habitueller Husten im Kindes- und Jugendalter
- 28 October 2016
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 165 (5) , 433-436
Habitueller Husten im Kindes- und Jugendalter
- Open Access
Factors augmenting allergic reactions
Elicitors of anaphylactic reactions are any sources of protein with allergenic capacity. However, not all allergic reactions end up in the most severe form of anaphylaxis. Augmenting factors may explain why certain conditions lead to anaphylaxis. Augmenting factors may exhibit three effects: lowering the threshold, increasing the severity, and reversing acquired clinical tolerance. Common augmenting factors are physical exercise, menstruation, NSAIDs, alcohol, body temperature, acute infections, and antacids. Therapeutic options may address causative, preventive, pragmatic, or symptomatic considerations: avoid the eliciting food, take an antihistamine before any situation with a possible risk of augmentation, separate food and sport (at least for 2 h), and carry an adrenaline autoinjector at all times. Individual patterns include summation effects and specific patterns. In conclusion, in the case of a suggestive history but a negative oral challenge, one should consider the possible involvement of augmenting factors; after anaphylactic reactions, always ask for possible augmentation and other risk factors during the recent past; if augmentation is suspected, oral food challenges should be performed in combination with augmenting factors; and in the future, standardized challenge protocols including augmenting factors should be established.
Open AccessFactors augmenting allergic reactions
Elicitors of anaphylactic reactions are any sources of protein with allergenic capacity. However, not all allergic reactions end up in the most severe form of anaphylaxis. Augmenting factors may explain why certain conditions lead to anaphylaxis. Augmenting factors may exhibit three effects: lowering the threshold, increasing the severity, and reversing acquired clinical tolerance. Common augmenting factors are physical exercise, menstruation, NSAIDs, alcohol, body temperature, acute infections, and antacids. Therapeutic options may address causative, preventive, pragmatic, or symptomatic considerations: avoid the eliciting food, take an antihistamine before any situation with a possible risk of augmentation, separate food and sport (at least for 2 h), and carry an adrenaline autoinjector at all times. Individual patterns include summation effects and specific patterns. In conclusion, in the case of a suggestive history but a negative oral challenge, one should consider the possible involvement of augmenting factors; after anaphylactic reactions, always ask for possible augmentation and other risk factors during the recent past; if augmentation is suspected, oral food challenges should be performed in combination with augmenting factors; and in the future, standardized challenge protocols including augmenting factors should be established.